Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 11—November 2022
Research

Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, Spain

Oriol GaschComments to Author , Laia Badia-Cebada, Joao Carmezim, Montserrat Vaqué, Virginia Pomar, Encarna Moreno, Anna Marrón, Emili Jiménez-Martínez, Maria José García-Quesada, Xavier Garcia-Alarcón, Dolors Domènech, Jordi Càmara, Marta Andrés, Judith Peñafiel, Rosario Porrón, Enric Limón, Esther Calbo, and Miquel Pujol
Author affiliations: Universitat Autònoma de Barcelona, Barcelona, Spain (O. Gasch); Hospital Universitari Parc Taulí I3PT, Sabadell, Spain (O. Gasch, L. Badia-Cebada, A. Marrón); Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain (J. Carmezim, J. Càmara, J. Peñafiel, M. Pujol); Hospital de Barcelona, Barcelona (M. Vaqué); Hospital de la Santa Creu i Sant Pau, Barcelona (V. Pomar); Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain (E. Moreno); Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (E. Jiménez-Martínez, J. Càmara, M. Pujol); Hospital Germans Trias i Pujol, Badalona, Spain (M.J. García-Quesada); Hospital Josep Trueta, Girona, Spain (X. Garcia-Alarcón, D. Domènech); Hospital Consorci de Terrassa, Terrassa, Spain (M. Andrés); VINCat, Barcelona (R. Porrón, E. Limón); Universitat de Barcelona, Barcelona (E. Limón); Hospital Universitari Mútua Terrassa, Terrassa (E. Calbo)

Main Article

Table 1

Incidence rates of CRB per 1,000 patient-days in 2020 stratified by catheter characteristics and microorganisms in study of effects of the COVID-19 pandemic on incidence and epidemiology of catheter-related bacteremia, Spain*

Category Observed rate Predicted rate Observed/predicted (95% CI) RMSE
Location acquired
ICU 1.62 0.48 3.42 (3.04–3.79) 1.147
Non-ICU
 0.19
 0.12
 1.51 (1.37–1.65)
 0.062
Catheter type
CVC 0.16 0.06 2.54 (2.29–2.78) 0.094
PICVC 0.06 0.04 1.73 (1.46–2.00) 0.025
PVC 0.06 0.05 1.24 (1.06–1.43) 0.012
Catheter insertion site
Arm/forearm 0.12 0.08 1.45 (1.29–1.60) 0.038
Jugular 0.09 0.03 2.64 (2.30–2.97) 0.056
Subclavian 0.04 0.02 1.88 (1.53–2.22) 0.020
Femoral
 0.02
 0.01
 3.12 (2.27–3.96)
 0.013
Catheter use
Serum/medication 0.22 0.10 2.14 (1.97–2.31) 0.117
Hemodialysis 0.00 0.00 1.25 (0.51–1.99) 0.001
Parenteral nutrition 0.06 0.03 1.62 (1.36–1.89) 0.021
Microorganism
Staphylococcus aureus 0.06 0.04 1.26 (1.06–1.46) 0.012
Coagulase-negative staphylococci 0.11 0.05 2.41 (2.14–2.68) 0.066
Gram-negative bacteria 0.04 0.03 1.69 (1.38–2.01) 0.017
Enterococcus sp. 0.03 0.01 5.41 (4.16–6.65) 0.022
Pseudomonas aeruginosa 0.01 0.01 2.20 (1.46–2.94) 0.007
Candida sp. 0.02 0.01 2.24 (1.59–2.90) 0.009

*We predicted expected rates of CRB by using negative binomial regression models and compared predicted rates with observed CRB rates in 2020. CRB, catheter-related bacteremia; RMSE, root mean squared error; ICU, intensive care unit; CVC, central vascular catheter; PICVC, peripherally inserted central vascular catheter; PVC, peripheral vascular catheter.

Main Article

Page created: September 15, 2022
Page updated: October 21, 2022
Page reviewed: October 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external